Effect of Combined Immune Therapy on Histology of Allograft and Th1/Th2 Cytokine Profile in Rat Orthotopic Liver Transplantation

LIU Hua,WU Zhi-yong,CAO Hui
DOI: https://doi.org/10.3969/j.issn.1005-6947.2007.08.009
2007-01-01
Abstract:Objective To study the effect of combined immune therapy with anti-CD40L mAb and low-dose cyclosporine(CsA) on the liver graft survival in rats,and Th1/Th2 cytokine profile.Methods Recipients were divided into the following groups.Group A: SD→SD rats,Group B: SD→Wistar rats without any treatment,Group C: SD→Wistar rats with CsA monotherapy from d1 to d5,Group D: SD→Wistar rats with CsA from d1 to d5 and anti-CD40L mAb in d0 and d2.The recipient survival and liver graft pathology observed.On post-transplant d7 ELISA technique was used to detect the level of cytokines in peripheral blood.Results The survival period of recipients in Group A and D was significantly longer than that in Group B and C.Mild to severe acute rejection reactions were observed in liver specimens from Group B and C while the degree of tissue injury in specimens from Group D was decreased signiflcantly.The serum levels of IL-2 and IFN-γ in Group B were significantly higher than those in other groups.On the contrary,the serum level of IL-4 and IL-10 in Group D was elevated much more than that in Group B(P0.05).Conclusions The combined immune therapy can prolong graft survival and effectively suppress acute rejection in ROLT.High expression of Th2 cytokines is beneficial to long-term survival of recipients and graft.
What problem does this paper attempt to address?